Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed London Stock Exchange  -  11:35:12 2023-02-01 am EST
10280.00 GBX   -2.93%
01:40pAnalysis-GSK gives few clues on plans to replenish medicine cabinet
RE
12:17pFTSE 100 Closes Down 0.1% as Market Awaits Fed Meeting
DJ
11:28aAstrazeneca : Transparency Directive - Form 6-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca Unit to Acquire LogicBio Therapeutics; LogicBio Shares Soar

10/03/2022 | 07:41am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -2.93% 10280 Delayed Quote.-5.60%
All news about ASTRAZENECA PLC
01:40pAnalysis-GSK gives few clues on plans to replenish medicine cabinet
RE
12:17pFTSE 100 Closes Down 0.1% as Market Awaits Fed Meeting
DJ
11:28aAstrazeneca : Transparency Directive - Form 6-K
PU
11:00aTelecoms, Natural Resources Lead European Equities Lower in Wednesday Trading
MT
06:05aASTRAZENECA : JP Morgan remains its Buy rating
MD
01:32aNovartis says operating profit to grow again ahead of Sandoz spin-off
RE
01/31ASTRAZENECA : Gets a Buy rating from JP Morgan
MD
01/31European shares drop as focus shifts to cenbank meetings
RE
01/31Marketmind: Mind the gap
RE
01/30Drugmakers prevail in dispute over U.S. discount drug program
RE
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 44 443 M - -
Net income 2022 4 125 M - -
Net Debt 2022 24 469 M - -
P/E ratio 2022 49,3x
Yield 2022 2,26%
Capitalization 202 B 202 B -
EV / Sales 2022 5,10x
EV / Sales 2023 4,80x
Nbr of Employees 83 100
Free-Float 96,5%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 130,45 $
Average target price 153,22 $
Spread / Average Target 17,5%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC-5.60%202 170
JOHNSON & JOHNSON-7.49%427 259
ELI LILLY AND COMPANY-6.93%327 004
NOVO NORDISK A/S0.53%310 851
ROCHE HOLDING AG-1.81%274 452
MERCK & CO., INC.-3.19%272 327